EGFR and central nervous system cancer: As an alternative, we considered DYRK1A (dual-specificity tyrosine phosphorylation-regulated kinase 1A), as we have previously demonstrated that this kinase promotes the stability of EGFR in adult neural progenitors [11] and glioma cells, where it controls the growth and the survival of the tumors [12].